Adenovirus DNA is rapidly lost in actively dividing cells. In addition, first-generation (E1-defective) vectors trigger a strong cytotoxicity that impairs the duration of transgene expression. To solve these issues, we have developed a chimeric vector system that uses E1/E4 doubly defective adenoviruses for efficient production of infectious retroviral vectors. The retroviral vector sequences and packaging functions were split into two E1/E3/E4-deleted adenoviral vectors: the Moloney murine leukemia virus gag-pol cistron was expressed from the human EF1␣ (elongation factor) promoter (AdGAG/POL), whereas the thymidine kinase transgene, embedded in a retroviral vector context, and an amphotropic retroviral envelope cassette were included within a second adenovirus (AdTK/ENV). This chimeric vector system was evaluated with a special emphasis on recombinant retrovirus production in vitro, as well as transgene amplification and persistence in vivo. Retrovirus titers of Ͼ10 5 infectious units/mL were routinely obtained in W162 cells coinfected with both recombinant adenoviruses. Long-term transgene persistence (up to 3 months) was demonstrated in vitro in two different cell lines coinfected with AdGAG/POL and AdTK/ENV, and correlated with the detection of specific provirus sequences. A 10-to 50-fold transgene amplification also was demonstrated in an in vivo tumor model infected with the Ad/Rt chimeric vector system. The chimeric vector system described herein combines the efficiency of gene delivery by recombinant adenoviruses with the integrative properties of infectious retroviral vectors. This versatile vector system may open up new avenues for efficient production of oncogenic, but also non-oncogenic, retroviruses from cells of non-murine origin.
fficient delivery and stable expression of a therapeutic gene in vivo will likely be required for several gene therapy indications, including anti-angiogenic strategies to fight cancer and the phenotypic correction of many genetic deficiencies. So far, both features are not satisfactorily displayed by the vectors currently being evaluated in gene therapy protocols.
Retroviral vectors have been used successfully to deliver genes into a wide range of cell types in vitro as well as into tissues within experimental models. 1, 2 Most importantly, these vectors integrate efficiently into the target cell genome, and thus promote stable gene delivery. Retroviral integration is precise with respect to the transferred information, leading to sustained transgene expression. 3, 4 However, a significant hurdle still relies on the difficulty in producing high-titer viral stocks for efficient in vivo delivery. 2 Adenoviral vectors exhibit complementary features. For example, they can be grown to very high titers and transduce many different tissues in vivo. 5 First-generation vectors based on early region E1 and E3 deletions, however, cannot achieve stable transgene delivery and expression in immunocompetent models, partly because they trigger a strong cytotoxic immune response toward the virally infected cells. 6, 7 More disabled vectors are currently being evaluated, including the additional inactivation of early region E4. 5 For example, administration of E1/E4 doubly defective vectors in the livers of mice immunotolerant for the transgene product has been shown to dramatically extend the survival of the virally infected cells. 8, 9 Transgene expression in the absence of E4, however, is impaired, especially when promoters that respond to inflammatory factors are being used to drive expression. 9 -11 To combine the advantages of adenoviral and retroviral vectors with regard to efficient gene delivery and stable genetic transduction in vivo, we have developed a chimeric vector system in which the retroviral elements required for recombinant retrovirus production are displayed by two defective adenoviruses. Also, E1/E4 doubly defective adenoviruses were used as carriers to take advantage of their innocuity, a prerequisite for stable gene transfer in vivo. 8, 9 Herein, we report the evaluation of this chimeric vector system in vitro and in vivo, with a special emphasis on transgene amplification and persistence.
MATERIALS AND METHODS

Cells
IGRP2 cells, an E1/E4-transcomplementing cell line derived from 293 12 and W162 cells 13 were maintained in minimum Eagle's medium supplemented with 10% fetal bovine serum (FBS). Human-derived NCI-H460 non-small cell carcinoma cells (HTB177; American Type Culture Collection, Manassas, Va) and NIH-3T3 fibroblasts were cultivated in Dulbecco's modified Eagle's medium and RPMI 1640, respectively, supplemented with 10% FBS. All cells were grown at 37°C in 5% CO 2 .
Recombinant adenoviruses
The HindIII/XbaI fragment containing the human EF1␣ (elongation factor) promoter 14 was cloned between the HindIII and XbaI of pSI (Promega Biotec, Madison, Wis) to generate pSI-EF1␣. The XbaI restriction fragment from pMOV-3⌬Cla (obtained from T. Heidmann, Centre National de la Recherche Scientifique Unité Propre de Recherche 147, Villejuif, France), containing the Moloney murine leukemia virus (MoMLV) gag-pol genes, was cloned into the XbaI site of pSI-EF1␣ to generate pEF1␣-GP. An EcoRI/BsrGI polymerase chain reaction (PCR) fragment containing the gag-pol translation initiation site was amplified from pMOV-3⌬Cla with an upstream primer, 5Ј-CCGGAATTCGCCGCCACCA-TGGGCCAGACTGTTACC-3Ј, and a downstream primer, 5Ј-GGAGGCGGAGGCTTAGGGTG-3Ј, and cloned between the EcoRI and BsrGI sites of pEF1␣-GP to generate pEF1␣-GPaug. An XbaI/NotI PCR fragment containing the MoMLV gag-pol stop codon was amplified from pMOV-3⌬Cla with an upstream primer, 5Ј-GTAGACGGCATCGCAGCTTG-3Ј, and a downstream primer, 5Ј-AAAAAAAAGCGGCCGCT-CATTAGGGGGCCTCGCGGG-3Ј, and cloned between the corresponding sites of pEF1␣-GPaug to generate pEF1␣-GPϩ. The FspI restriction fragment from pEF1␣-GPϩ, containing the gag-pol gene cassette expression, was inserted into the EcoRV site of pXL3048 (containing the Ad5 sequence from position 1 to 382 and the pIX-encoding sequence from position 3446 to 4296) to generate the shuttle plasmid pAdEGP.
An XbaI/NotI PCR fragment containing the amphotropic 4070A env gene was amplified from pSV-envAM (obtained from T. Heidmann) by use of an upstream primer, 5Ј-GGCTCTAGAGCCGCCACCATGGCGCGTTCAACGC-TC-3Ј, and a downstream primer, 5Ј-AAAAAAAAGCGGC-CGCTTATCATGGCTCGTACTCTATGG-3Ј, and cloned between the XbaI and NotI sites of pSI-EF1␣ to generate pEF1␣-Env.
The BstYI/NarI fragment containing the herpes simplex virus-1 (HSV-1) thymidine kinase (tk) gene was cloned between the BclI and ClaI sites of retroviral vector pLNCX 15 The shuttle plasmids pAdEGP and pAdCLTKEE were used to generate the corresponding ⌬E1 (nucleotides 382-3328)/ ⌬E3 (nucleotides 28592-30470)/⌬E4 (nucleotides 33423-35355) adenoviral backbones, pAdGAG/POL and pAdTK/ ENV, respectively, by recombinational cloning in Escherichia coli as described previously. 16 Restriction analysis and partial automated sequencing (EuroSequence Gene Service, St. Malo, France) were used to check both adenoviral backbones (Fig 1) .
Adenovirus amplification and titration
The recombinant adenoviruses AdTK/ENV and AdGAG/POL were recovered after transfection of IGRP2 cells with the corresponding PacI-restricted pAdTK/ENV and pAdGAG/ POL backbones as described previously. 16 Viral prestocks were aliquoted and stored at Ϫ20°C. Restriction analysis and partial automated sequencing were used to check the integrity of both adenoviruses.
Viral titration was performed in IGRP2 cells by an immunoperoxidase assay with a monoclonal antibody (Ab) specific to the Ad5 penton protein (Biodesign International, Kennebunkport, Me). Viral titers were expressed as infectious units (IU) per milliliter and viral particles per milliliter as determined by high-performance liquid chromatography (T. Guillemin, A. Barbot, and F. Blanche, RPR-Gencell, Vitry-surSeine, France).
Adenovirus infection
Subconfluent cells were infected at a known multiplicity of infection (MOI) in culture medium supplemented with 2% FBS. After 1 hour at 37°C, cells were washed twice with phosphate-buffered saline (PBS) and fresh complete medium was added. For long-term analysis, infected cells were mixed at 24 hours postinfection (p.i.) with noninfected cells at a 1:3 ratio, and cultures were passed twice a week.
Recombinant retrovirus infection
All retroviral infections were performed by adding diluted virus-containing medium to the cells. One day before infection, cells were seeded at 1.5 ϫ 10 5 cells/60-mm plate. Freshly harvested viruses were filtered (0.45-m pore-size filter) and polybrene (Sigma, St. Louis, Mo) was added at a concentration of 8 g/mL.
To determine the titers of TK retroviral vectors, serial dilutions of viral supernatant were used to transduce NIH-3T3 in 6-well plates (2 ϫ 10 5 cells/well). Diluted supernatants were added to 2 mL of culture medium and left on the cells for 48 hours. At this time, the percentage of TK-positive cells was determined by flow cytometry analysis (see below), and titers were expressed as IU per milliliter.
Flow cytometry analysis
Infected cells (10 6 ) were washed with PBS, trypsinized, and fixed for 30 minutes in 4% formaldehyde-PBS at room temperature. They were then permeabilized in 0.2% Triton X-100-PBS for 10 minutes at room temperature, washed three times with 1ϫ Power Block (BioGenex Laboratories, San Ramon, Calif), and incubated for 2 hours at room temperature with an anti-HSV-1 TK rabbit polyclonal Ab (pAbTK41, dilution 1/250; kindly provided by M. Janicot, RPR-Gencell, Vitry-surSeine, France). The cells were washed three times with 1ϫ Power Block before being incubated with donkey anti-rabbit fluorescein isothiocyanate-coupled immunoglobulin G (Jackson ImmunoResearch Laboratories, West Grove, Penn; dilution 1/250) for 1 hour at room temperature. They were then washed three times with 1ϫ Power Block and resuspended in PBS for flow cytometry analysis. Values are given as means of triplicate experiments Ϯ SE.
PCR analysis
Total DNA was purified from 10 7 cells or tissue (50 mg) with the QIAamp blood kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The forward and reverse oligonucleotides specific for the TK provirus (the U3/TK primer set) were 5Ј-GCTAGCTTAAGTAACGCCATTT-TGC-3Ј (oligonucleotide U3) and 5Ј-GCGCCAGGT-CG-CATATCGTCGG-3Ј (oligonucleotide TK), giving rise to a 2610-bp product. PCR was performed on 2 g of DNA for 40 cycles at a denaturing temperature of 95°C for 45 seconds, an annealing temperature of 62°C for 45 seconds, and an extension temperature of 72°C for 4 minutes 30 seconds. The PCR PSI/TK primer set included oligonucleotide TK (see above) and 5Ј-GCTCGTCCGGGATTTGGAGACCC-3Ј (oligonucleotide PSI), generating a 2041-bp fragment from both the TK provirus and AdTK/ENV DNA. PCR amplification was performed for 35 cycles as described above, except that the annealing temperature was 65°C. As a loading control for standardization, PCR was performed on each total DNA sample with the human ␤-actin control amplimer set (Clontech, Palo Alto, Calif) according to the manufacturer's instructions. PCR products were visualized on a 1% agarose gel by ethidium bromide (EtBr) staining. PCR products were purified from the reaction mix with the QIAquick PCR Purification kit (Qiagen) according to the manufacturer's instructions.
Reverse transcription (RT)-PCR analysis
Total RNA was first extracted with the RNA-Plus kit (Quantum Bioprobe, Illkirch, France). Polyadenylated RNAs were then purified with cellulose oligo(dT) columns (Life Technologies, Gaithersburg, Md) according to the manufacturer's instructions. RT-PCR was performed on 200 ng of mRNA with the Access RT-PCR system (Promega Biotec) for 45 minutes at 48°C, 2 minutes at 94°C, and 40 cycles at a denaturing temperature of 94°C for 45 seconds; an annealing temperature of 60°C for 45 seconds; and an extension temperature of 72°C for 3 minutes. The primers for RT-PCR were the PSI and TK oligonucleotides (see above). PCR products were visualized by EtBr staining after electrophoresis on a 0.8% agarose gel.
Quantitative slot-blot analysis
A total of 1 L from each PCR PSI/TK and PCR ␤-actin reaction mix (dilution 1, 1/10, and 1/100) were heated in 0.4 M NaOH/2.2 mM ethylenediaminetetraacetic acid at 95°C for 2 minutes and transferred to a Hybond-N ϩ nylon membrane (Amersham Pharmacia Biotech, Little Chalfont, UK). DNA was fixed by baking the membrane at 80°C for 2 hours. The membrane was prehybridized for 2 hours at 65°C in 0.25 M NaH 2 PO 4 , 0.25 M Na 2 HPO 4 , and 7% sodium dodecyl sulfate (SDS), followed by overnight hybridization at 65°C in the same buffer. It was then washed twice at 65°C in 2ϫ standard saline citrate (SSC)/0.1% SDS for 5 minutes, twice at 65°C in 2ϫ SSC/0.1% SDS for 15 minutes, and twice at 65°C in 0.1ϫ SSC/0.1% SDS for 30 minutes, before exposure to Fuji RX film The TK, ENV, and GAG/POL expression cassettes are represented. R, U3, and U5 refer to the subsequences from the MoMLV LTR, respectively. ⌿ϩ refers to the extended retroviral packaging sequence. B: pAdTK/ENV and pAdGAG/POL backbones and the corresponding adenoviral DNAs were restricted with BglII and run on a 0.7% agarose gel. Lanes M, 1-kb marker (Life Technologies); lanes 1 and 2, pAdTK/ENV and pAdGAG/POL backbone DNA, respectively; lanes 3 and 4, AdTK/ENV and AdGAG/POL adenoviral DNA, respectively.
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at Ϫ80°C with an intensifying screen. The probe corresponded to the HSV-1 tk gene (AccI/PstI fragment from pLTK) that was randomly labeled with [␣-32 P]deoxycytidine triphosphate. For the ␤-actin product, hybridization with a 30-nt oligonucleotide from the human ␤-actin gene (Clontech) was performed. Membranes were exposed to Fuji imaging plates (type BAS-IIIS) and analyzed with a Fujix Bas 1000 phosphor imager with the MacBAS 2.2 program (Fuji Photo Film Co.).
RT assays
RT activity was quantified as described previously. 17 Briefly, 30-L samples mixed with 20 L of reaction cocktail were incubated at 37°C for 60 minutes. Samples were analyzed by autoradiography or with a Fujix Bas 1000 phosphor imager (see above). Positive controls for RT activity were GPϩenvAm12 cell supernatants. 18 Tumor grafting NCI-H460 cells were first infected in vitro at 100 IU/cell. After 18 hours, the cells were washed with PBS and harvested before subcutaneous injection (5 ϫ 10 6 cells) into the flanks of 4-to 6-week-old female nude Swiss mice. After 23 days, the tumors were harvested and analyzed. All experiments were done in accordance with guidelines from the French Council of Animal Care and Testing.
RESULTS
Construction of AdGAG/POL and AdTK/ENV
Two E1/E3/E4-deleted recombinant backbones were first constructed by recombinational cloning in E. coli. 16 In the first backbone, the MoMLV gag-pol cistron expressed from the human EF1␣ promoter has been inserted in place of the E1 genes (pAdGAG/POL, see Materials and Methods). In the second backbone, the 4070A amphotropic env protein expressed from the human EF1␣ promoter and the CMV/HSV-1 tk expression cassette containing the MoMLV PSI ϩ packaging sequence had been inserted in place of the E1 genes (pAdTK/ENV, see Materials and Methods).
With the aim to minimize the risk of recombination during backbone construction in E. coli and/or virus amplification in IGRP2 cells, the 5Ј and 3Ј long terminal repeats (LTRs) have been engineered such that R (68 nt) is the only region of homology left (Fig 1A) . Otherwise, the retroviral expression constructs were designed to prevent any risk of replication-competent retrovirus production. The gag-pol and env cistrons are separated on two different adenoviruses, in which the LTRs and packaging signal are removed. In addition, env and gag-pol sequences are restricted to the open reading frames. Such features are commonly used to construct safe and efficient retroviral packaging cell lines. 19, 20 It is generally assumed that recombinant adenoviruses resulting in viral DNA less than a net genome size of 105% of that of the wild-type Ad5 genome length are genetically stable and grow to normal titers. 21 Transfection of the pAdGAG/POL and pAdTK/ENV backbones in IGRP2 generated the corresponding AdGAG/POL and AdTK/ENV adenoviruses. AdGAG/POL and AdTK/ENV had net genome sizes of 101.4% and 101.8% of the wild-type Ad5 genome, respectively. As checked by restriction analysis (Fig 1B) and partial sequencing, the identity and integrity of both adenoviral genomes were confirmed. The retroviral sequences, and especially the repeated R sequences on both sides of the HSV-1 TK gene, did not recombine. Prestocks of AdTK/ ENV and AdGAG/POL were obtained with a normal productivity (i.e., ranging from 3.3 to 5.8 ϫ 10 8 IU/mL, or 1.3 to 1.9 ϫ 10 10 viral particles/mL). Expression of the retroviral functions did not interfere with completion of the adenoviral infectious cycle in IGRP2 cells. (Fig 2, A and B) . TK was synthesized to very similar levels in the coinfected cells, with an MFI of 16.4 (Fig 2C) . Similar results were obtained when NIH-3T3 cells were used (data not shown).
The functionality of the MoMLV gag-pol cistron was demonstrated by an RT assay performed on culture supernatants of W162 cells infected with AdTK/ENV or AdGAG/POL or coinfected with AdTK/ENV and AdGAG/POL. As shown in Table 1 , high levels of RT activity were detected in AdGAG/POL-infected cell supernatants, whereas no RT activity was detectable in the medium from noninfected and AdTK/ENV-infected cells. RT activity was also equivalent in the culture medium from coinfected and AdGAG/POL-infected cells. Interestingly, the RT activity from AdGAG/POLinfected cell supernatants was 11-to 34-fold higher than that from the standard GPϩenvAm12-packaging cell line. 18 The infectivity of the recombinant retroviruses (i.e., expression of a functional env gene) was demonstrated by flow cytometry quantification of TK intracellular levels after infection of NIH-3T3 cells with the conditioned medium from AdTK/ENV-and AdGAG/POLcoinfected W162 cells (see Materials and Methods).
Titers of Ͼ10
5 IU/mL were obtained, outlining the potential of this Ad/Rt chimeric vector system to produce high-titer recombinant retroviruses compared with conventional transient methods. 2, 18 To optimize retroviral production parameters with the Ad/Rt vector system, W162 cells were infected with AdTK/ENV and AdGAG/POL at different MOIs, and RT activity was determined after 48 hours. As shown in Table 1 , there is a positive correlation between MOI and RT activity (up to 200 IU/cell). At higher MOIs (300 and 500 IU/cell), there was no further increase in RT activity. Very similar results were recently reported by Duisit et al 22 after infection of human cells with a MoMLV gag-pol-expressing adenovirus. Analysis of gag proteins by Western blot, with Abs recognizing the uncleaved Pr65 gag precursor, indicated that the expression of this precursor saturated when high MOIs were applied on target cells. The primary mechanism suspected is the premature intracellular cleavage of the Pr65 gag precursor, affecting retroviral particle production. 22 Interestingly, high RT activity persisted for Ͼ1 week after coinfection (Fig 3) , again emphasizing the usefulness of our hybrid system for retrovirus production compared with standard transient procedures for which RT activity rapidly declines after a 48-to 96-hour period. 2 
In vitro long-term transgene persistence and expression
The persistence of the tk transgene delivered by the Ad/Rt vector system was demonstrated in a long-term in vitro assay. For this purpose, NIH-3T3 and W162 cells were used. E1/E4-deleted adenoviruses do not replicate in these two cell lines at the MOIs used (E. Vigne, unpublished observations). 13 Their use herein therefore validates our data on transgene persistence (see below). NIH-3T3 and W162 cells coinfected with AdTK/ENV and AdGAG/POL (MOI of 200 IU/cell for each virus) were mixed at a 1:3 ratio with noninfected cells before being passaged twice weekly for 59 and 94 days, respectively. Noninfected cells and AdTK/ENV-infected cells (MOI of 200 IU/cell) were used in parallel as controls.
Retroviral integration results in duplication, during the RT process, of the 3Ј U3 sequence to form a complete LTR (U3 R U5) at the 5Ј end of the provirus. Retrovirus-mediated integration was therefore assessed by PCR analysis of genomic DNA [23] [24] [25] with a set of primers (U3/TK) specific to the TK provirus, leading to the amplification of a 2610-bp fragment (Fig 4A) . The TK sequence from AdTK/ENV DNA cannot be amplified with the U3/TK primer set because the U3 region was not included upstream of the HSV-1 tk expression cassette ( Fig 1A) . As shown in Figure 4B , transgene integration was detected only in cells that had been coinfected with AdTK/ENV and AdGAG/POL, and at all timepoints tested (W162: day 20, 28, 52, and 94 p.i.; NIH-3T3: day 17 and 59 p.i.). In contrast, no TK provirus could be detected in W162 and NIH-3T3 cells infected with AdTK/ENV alone. The identity and integrity of the PCR U3/TK amplification product were confirmed by restriction analysis (Fig 4C) . Proviral integration also was confirmed by Southern blot analysis of genomic DNA (XbaI-restricted) with a radiolabeled TK probe (data not shown).
An oligonucleotide complementary to the MoMLVpackaging sequence (oligonucleotide PSI) also was used with the TK oligonucleotide to document transgene integration. In contrast to the U3/TK set of primers described above, the PSI/TK primer set does not differentiate between adenoviral AdTK/ENV DNA and the provirus sequence (Fig 5A) . Despite this, no PCR product could be detected in AdTK/ENV-infected NIH-3T3 and W162 cell cultures as early as days 17 and 20 p.i., respectively (Fig 5B) , indicating that the adenoviral chromosome is rapidly lost in proliferating cells as expected (H. Leblois-Prehaud, unpublished data). This is in sharp contrast to the coinfected cells for which the cognate 2041-bp PCR product was readily amplified ( Fig  5B) . Again, the identity and integrity of the PCR product was assessed by restriction analysis (Fig 5C) and detection with a radiolabeled specific probe (data not shown). Consistent with these results, the presence of TK-encoding polyadenylated RNAs was demonstrated after 26 days by RT-PCR analysis with the PSI/TK set of primers in coinfected NIH-3T3 cells, but not in cells infected with AdTK/ENV alone (Fig 6) . Taken together, we conclude that retrovirus-mediated transgene delivery with our chimeric vector system dramatically extends transgene persistence in proliferating cells in vitro.
In vivo transgene amplification
The functionality of the Ad/Rt vector system was further evaluated in an in vivo model. The human-derived lung carcinoma cell line NCI-H460 was used. E1/E4-deleted adenoviruses do not replicate in this cell line (data not shown). H460 cells were infected in vitro with a combination of AdTK/ENV and AdGAG/POL (MOI of 100 IU/cell for each virus) or with AdTK/ENV alone (MOI of 100 IU/cell). Flow cytometry analysis first indicated that these infection conditions led to ϳ25% of TKpositive cells (data not shown). At 20 hours p.i., 5 ϫ 10 6 cells were implanted subcutaneously in athymic nude mice (n ϭ 4). Noninfected cells were implanted in parallel as additional control animals (n ϭ 2). Animals were sacrificed at day 23 postimplantation, and tumors were harvested for analysis of transgene amplification and persistence.
PCR PSI/TK analysis of tumors that developed after coinfection with AdTK/ENV and AdGAG/POL (tumors G-J) indicated that they contained a higher number of tk gene copies compared with tumors that only received the AdTK/ENV adenovirus (tumors C-F; Fig 7A, compare lanes C-F with lanes G-J) or tumors that were not virally infected (tumors A and B) . In contrast to our in Figure 4 . In vitro provirus amplification. A: Representation of the TK provirus. R, U3, and U5 refer to the subsequences from the MoMLV LTRs, respectively. ⌿ϩ refers to the extended MoMLV packaging sequence. Oligonucleotides U3 and TK are separated by 2610 bp and were used for genomic PCR amplification. B: PCR amplification of 2 g of genomic DNA from noninfected, AdTK/ENV-infected, and AdTK/ENV-plus AdGAG/POL-coinfected W162 and NIH-3T3 cell cultures. Lanes M, 1-kb marker (Life Technologies); lane Ϫ, no DNA; lane ϩ, plasmid pLTK; lanes 1-3, extract from noninfected, AdTK/ ENV-infected, and AdTK/ENV-plus AdGAG/POL-coinfected W162 cells 94 days p.i., respectively; lanes 4 -6, extract from noninfected, AdTK/ENV-infected, and AdTK/ENV-plus AdGAG/POL-coinfected NIH-3T3 cells 59 days p.i., respectively. C: PCR product was purified (lane 1) before digestion with HindIII (lane 2), generating fragments with the expected size (1505 and 1105 bp; see (A) ). Lanes M, 1-kb marker (Life Technologies). PCR products were run on a 1% agarose gel and stained with EtBr.
vitro results in W162 and NIH-3T3 cells infected with AdTK/ENV alone, for which no AdTK/ENV could be detected with the PSI/TK primer set at 20 and 17 days p.i., respectively (Fig 4B) , a faint signal was detected after 23 days in two of four NCI-H460 tumors infected with AdTK/ENV (Fig 7A, lanes C and D) . A lower rate of division in this in vivo model compared with the W162 and NIH-3T3 in vitro models most likely accounts for this difference. Most importantly, evaluation of the tk gene copy number by quantitative slot-blot analysis supported a 10-to 50-fold increase in tumors cells infected with the Ad/Rt chimeric system compared with those infected with AdTK/ENV alone (Fig 7B) .
Integration of the tk gene was demonstrated by PCR U3/TK [23] [24] [25] in all tumors derived from H460 cells infected with AdTK/ENV and AdGAG/POL (Fig 8, lanes  G-J) , whereas as expected, there was no evidence of TK provirus in control tumors derived from AdTK/ENVinfected cells or noninfected cells (Fig 8, lanes A-F) . Proviral integration also was confirmed by Southern blot analysis of genomic DNA (XbaI restricted) with a radiolabeled TK probe (data not shown).
For each of the four positive tumors (Fig 8, G-J) , the PCR U3/TK signal intensity visualized by EtBr staining (Fig 8) 
DISCUSSION
We reported previously that E1/E4-defective adenoviruses allow for long-term extrachromosomal persistence of the transgene in murine hepatocytes in vivo, with minimal virus-induced cytopathological effects and vector-specific host responses. 9 However, transgene expression was rapidly shut down, apparently because viral promoters that respond to inflammatory stimuli cannot be used to drive expression from this attenuated vector context. 9 -11 In addition, E1/E4-deleted chromosomes are quickly lost in proliferating tumor cells in vitro and in vivo (H. Leblois-Prehaud, unpublished observations; see also this report). These observations prompted us to develop a hybrid vector system combining the high efficiency of delivery and long-term genome persistence TORRENT, JULLIEN, KLATZMANN, ET AL: ADENOVIRUS-MEDIATED RETROVIRAL DELIVERY that characterize E1/E4-defective adenoviruses with the integrative properties of recombinant retroviruses. For safety reasons, the retroviral functions were split into two E1/E3/E4-deleted adenoviruses (AdGAG/POL and AdTK/ENV). Coinfected cells should thus behave as TK retrovirus-producing cells, allowing transgene amplification to the neighboring cells.
High-titer production of infectious retrovirus was readily achieved in vitro, outlining the potential and versatility of this chimeric Ad/Rt vector system to recover recombinant particles with different envelope glycoproteins, or from various mammalian species, to overcome complement-mediated inactivation of the particles in vivo. 26 Indeed, several groups have used recombinant adenoviruses to facilitate the in vitro production of recombinant retroviruses with desired features. For example, first-generation (E1-defective) adenoviruses expressing the MoMLV structural genes and the vesicular stomatitis virus G-protein from a tetracycline-regulated promoter have been used to produce vesicular stomatitis virus G-protein-pseudotyped retroviral vectors.
27,28 A first-generation adenovirus expressing a recombinant retroviral backbone also has been used to produce retroviruses from murine-packaging cell lines expressing alternative envelopes. 29 Novel retroviral producer cells also were developed after cotransduction with a retroviral vector and a first-generation adenovirus expressing the MoMLV genes. 23 Finally, two E1-defective adenoviruses have been used successfully to deliver MoMLVbased vectors. 30 Interestingly, this chimeric vector system allowed efficient and stable transgene delivery both in vitro and in vivo.
Our data provide further characterization of Ad/Rt hybrid vectors and complement the initial reports. Our chimeric vector system differs in several ways from the previous systems: (a) all of the retroviral functions were not incorporated within the adenovirus backbones in most studies; 23, 29 (b) the use of E1/E4-defective adenoviruses is an absolute prerequisite to extend the duration of retrovirus production by tumor-derived cells; 8, 9 (c) for safety reasons, the retroviral functions were split into different adenoviral backbones; and (d) the increased cloning capacity of our vector system should translate into higher adenovirus stability. 21 Long-term transgene persistence (Ͼ3 months) was achieved in vitro in actively dividing cells coinfected with AdTK/ENV and AdGAG/POL under conditions in which the adenoviral carrier backbones reached undetectable levels as early as 2 weeks p.i. A 10-to 50-fold transgene amplification also was demonstrated in vivo in Fig 5A) . PCR products were run on a 1% agarose gel and stained with EtBr. B: Serial dilutions (1/10) of the PCR amplification products were blotted onto a nylon membrane and hybridized to a radiolabeled TK probe. Serial dilutions (1/10) of PCR ␤-actin amplification products were used as loading controls (see Materials and Methods). Each slot corresponds to serial dilutions from a given tumor (1/1 to 1/100 from left to right). The oligonucleotides U3 and TK, which specifically amplify a 2610-bp fragment from the TK provirus, were used (see Fig 4A) . PCR products were run on a 1% agarose gel and stained with EtBr.
tumors coinfected with the Ad/Rt chimeric vectors compared with control tumors. Retroviral integration of the transgene was demonstrated both in vitro and in vivo with our chimeric Ad/Rt vector system. Taken together, the integrative properties of this Ad/Rt chimeric vector system allowed for remarkable levels of transgene amplification and persistence.
HIV-1-based retroviral vectors have recently shown promise for gene transfer because they can transduce nondividing cells. [31] [32] [33] These vectors proved highly efficient for in vivo delivery and stable expression of the transgene in several target tissues. 31, 32, 34 Currently, lentivirus-derived vectors are obtained through transient transfection protocols. 31, 35 Adapting the Ad/Rt chimeric vector system of this study to non-oncogenic retroviruses also should widen the number of clinical applications amenable to these vectors.
